Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease

  • Amanda R. Buckallew
  • , Katie B. Tellor
  • , Rachel Watson
  • , William Miller
  • , Gina Mbachu
  • , Cameron Whitlock
  • , Jay R. Seltzer
  • , Anastasia L. Armbruster

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)955-960
Number of pages6
JournalEuropean Journal of Clinical Pharmacology
Volume77
Issue number7
DOIs
StatePublished - Jul 2021

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Keywords

  • Aldosterone antagonist
  • Chronic kidney disease
  • Heart failure
  • Mineralocorticoid receptor antagonist
  • Renal impairment

Cite this